The ice recrystallization inhibition activity of various mono-and disaccharides has been correlated with their ability to cryopreserve human cell lines at various concentrations. Cell viabilities after cryopreservation were compared with control experiments where cells were cryopreserved with dimethylsulfoxide (DMSO). The most potent inhibitors of ice recrystallization were 220 mM solutions of disaccharides; however, the best cell viability was obtained when a 200 mM D-galactose solution was utilized. This solution was minimally cytotoxic at physiological temperature and effectively preserved cells during freeze-thaw. In fact, this carbohydrate was just as effective as a 5% DMSO solution. Further studies indicated that the cryoprotective benefit of D-galactose was a result of its internalization and its ability to mitigate osmotic stress, prevent intracellular ice formation and/or inhibit ice recrystallization. This study supports the hypothesis that the ability of a cryoprotectant to inhibit ice recrystallization is an important property to enhance cell viability post-freeze-thaw. This cryoprotective benefit is observed in three different human cell lines. Furthermore, we demonstrated that the ability of a potential cryoprotectant to inhibit ice recrystallation may be used as a predictor of its ability to preserve cells at subzero temperatures.
Introduction
Cryopreservation is used to preserve many biological materials. In the last decade, there have been tremendous developments in the field of regenerative medicine and in the utilization of hematopoietic stems cells. In addition, mesenchymal stem cells (MSCs) are now regarded as effective substitutes for autologous whole cell bone marrow (Quevedo et al. 2009 ). These cell types have changed the course of treatment for many malignant and non-malignant conditions in adults and pediatric patients (Wagner et al. 1992; Barker and Wagner 2002) . MSCs have been prominently featured in regenerative medicine as these cells have the ability to differentiate into many different cell types and have been successfully utilized to treat cartilage lesions (Can and Karahuseyinoglu 2007) , spinal cord injury (Sykova et al. 2006) , bone defects (Kraus and Kerker-Head 2006) and cardiac disease (Stamm et al. 2004) . Unfortunately, recent studies have correlated poor in vivo differentiation of these cells with low survival rates after cryopreservation, thus underscoring the need for improved cryopreservation protocols (Quevedo et al. 2009 ).
The mechanisms of cryo-injury are many and diverse. Generally, cells with highly permeable cell membranes tend to survive with fast cooling rates, whereas those with less permeable membranes need to be cooled at much slower rates. Hence, cryopreservation is performed with either slow or fast cooling rates depending on the cell type. In most instances, ice will prefer to form outside of the cell (Fowler and Toner 2005) . Formation of extracellular ice creates an increased osmotic pressure across the cell membrane. This "osmotic flux" intensifies as ice growth continues after the nucleation event. As the ice crystal grows, all solutes are excluded from the ice lattice and are concentrated in the extracellular medium. Cells with less permeable membranes will rupture with increasing osmotic pressure if they cannot dehydrate fast enough. The process of dehydration during freezing is somewhat of a "double-edged sword". In one instance, the amount of intracellular water decreases reducing the chance for intracellular ice formation, which is known to be a lethal process. However, it has been shown that dehydration and exposure to excessively high concentrations of electrolytes is also lethal to the cell (Mazur 2004) . This is referred to as solute damage or the "solute effect" and it facilitates damage to the cell membrane that is irreparable. Conversely, when cells are frozen very slowly, dehydration and excessive cell shrinkage facilitate cell death. Excessive dehydration can be prevented using cryoprotectants. Two classes of cryoprotectants are commonly employed. Non-penetrating cryoprotectants do not cross the cell membrane and hence remain outside the cell, thereby increasing the osmolality of the extracellular solution facilitating dehydration of the cell prior to freezing and preventing the formation of intracellular ice. Cell penetrating cryoprotectants, such as dimethylsulfoxide (DMSO) and glycerol, readily cross the cell membrane and decrease the concentration of intracellular electrolytes while maintaining greater cell volumes. The major problem with penetrating cryoprotectants is cytotoxicity due to the disruption of intracellular signaling (Song et al. 2000) . In summary, cryopreservation of cells using slow-freezing results in dehydration of the cell in response to increasing osmotic pressure as electrolytes are concentrated outside the cell during extracellular ice growth. Although dehydration of the cells helps to prevent intracellular ice growth, it is also detrimental to cell survival.
Cryopreservation using high cooling rates traps water inside the cell promoting the formation of intracellular ice (Karlsson et al. 1993 ). The exact mechanism by which this occurs is not clear (Toner and Cravelho 1990) ; however, most cryobiologists believe that damage of the plasma membrane occurs as a result of osmotic pressure leading to intracellular ice formation, which results in cell death (Muldrew and McGann 1990) . Practical fast-freezing protocols must dehydrate cells prior to freezing in order to mitigate intracellular ice formation. Hence, cryoprotectants are necessary but the role of the cryoprotectant in cryopreservation during fast cooling is different from slow cooling. Non-penetrating cryoprotectants are employed in an effort to dehydrate the cell and minimize the chance of intracellular ice formation. The correlation between intracellular ice formation and cell death has been recognized but evidence suggests that the formation of intracellular ice does not directly kill cells (Fowler and Toner 2005) . Studies have shown that the survival of cells postcryopreservation is dependent upon the rate at which the cells are warmed during thawing and that cell death associated with intracellular ice formation is not caused by the initial nucleation of ice, but by an alternate process during warming (Farrant 1977; Fowler and Toner 2005) . Possible mechanisms by which intracellular ice damages cells have been reviewed extensively in the literature and it has been concluded that cell death is occurring as a result of ice recrystallization (Mazur 2004) . This hypothesis is supported by the fact that may freeze-tolerant organisms inhabiting subzero environments produce large quantities of recrystallization inhibitors in vivo to ensure survival (Knight et al. 1988; Ramlov et al. 1996) .
A typical cryopreservation protocol involves the slow cooling of a sample in the presence of a cryoprotectant. DMSO, a penetrating cryoprotectant, is widely used. The exact mechanism by which DMSO protects cells remains a source of debate but it has been suggested that DMSO replaces water in the cell (Notman et al. 2006; Gurtovenko and Anwar 2007) . While the effectiveness of DMSO as a cryoprotectant is generally improved with increasing concentration, its toxic effects upon cells are both time-and temperature-dependent and have been thoroughly documented (Liseth et al. 2005; Elmoazzen et al. 2007 ). In clinical settings, the transplant of cells cryopreserved with DMSO has caused various cytotoxic effects in patients (Davis et al. 1990; Liseth et al. 2005) . Carbohydrate-based cryoprotectants are attractive alternatives to DMSO as they exhibit little or no cytotoxicity. Furthermore, carbohydrates resemble polyhydric alcohols such as glycerol, which is known to influence the structure of surrounding water and ice formation (Dashnau and Vanderkool 2007) . Carbohydrates have been shown to improve cell viability post-thaw (Tao et al. 1995; Hossain and Osuamkpe 2007; Eroglu et al. 2009; Mondal 2009 ) and are sometimes used in combination with DMSO (Vicente and Viudes-de-Castro 1996; Izadyar et al. 2002; Ma et al. 2006; Santos et al. 2006; Cui et al. 2007; Petrenko et al. 2008; Eroglu et al. 2009 ), glycerol Gutierrez-Perez et al. 2009 ) or 1,2-propanediol (Coticchio et al. 2006; Neto et al. 2008) . In other studies, the addition of carbohydrates to cell suspensions during cryopreservation actually decreases cell viability or gives no additional benefit (Son et al. 2004; Holovati et al. 2009; Valente et al. 2010) . In some instances, carbohydrates are included in the cryopreservation media but their efficacy is not evaluated (Muller-Schweinitzer et al. 2005 Berthelot et al. 2007; Park et al. 2007; Borges et al. 2009 ). In the studies where carbohydrates appear to be beneficial, the results appear to be dependent upon the structure of the carbohydrate used (Si et al. 2006; Yildiz et al. 2000 Yildiz et al. , 2007 . Additional complications arise because different cell types, different cooling rates and different concentrations of carbohydrates are used in these studies. Given these results, it is difficult to truly assess the effectiveness of carbohydrates as cryoprotectants.
Ice recrystallization has been identified as a significant factor in cell death during cryopreservation (Gage and Baust 1998; Baust 2002; Mazur 2004; Fowler and Toner 2005) . The mechanism of recrystallization has been studied extensively in the metallurgical and material science literature (Huige and Thijssen 1972; Knight et al. 1995; Pronk et al. 2005; Inada and Modak 2006) . However, the reasons that some compounds are better inhibitors of ice recrystallization than others are not known. Moreover, the key structural features necessary for effective ice recrystallization inhibition (IRI) have not been elucidated. Our laboratory has recently observed that while many carbohydrates display IRI activity, the magnitude of activity correlates with the degree of carbohydrate hydration (Tam et al. 2008 ). The present paper describes the first comprehensive study of the relationship between IRI activity, cytotoxicity and the cryopreservation ability of many carbohydrates with several human cell lines. Two of the three cell lines selected were human liver cells as liver cells are a convenient source of stem cells. The results from this study indicate a correlation between cryopreservation potential and the ability of a carbohydrate to inhibit ice recrystallization, which is ultimately related to its hydration. The broader implication of these finding is that novel cryoprotectants specifically designed to inhibit ice recrystallization may overcome the current limitations associated with existing cryoprotectants, thus facilitating the efficient preservation of not just cells but tissues and perhaps even organs. (D-melibiose, D-lactose, D-trehalose and D-sucrose) was quantified and is displayed in Figure 1 . Many of these carbohydrates are commonly employed in cryopreservation (Eroglu et al. 2000; Fowler and Toner 2005; Terry et al. 2005; Hossain and Osuamkpe 2007 ). All carbohydrates were tested at 22 and 220 mM concentrations. Solutions more concentrated than 220 mM were too viscous to use in our IRI assay. We have previously reported the IRI activity of these mono-and disaccharides at 22 mM concentration (Tam et al. 2008 ) and these findings are included in Figure 1 for comparison. With concentrations of 22 mM, IRI activity correlates well with the calculated hydration indices of the mono-and disaccharides. D-Galactose is the most potent monosaccharide and D-melibiose is the most potent disaccharide, both possessing similar IRI activities as predicted by their hydration indices (Tam et al. 2008) .
Results and discussion
At concentrations of 220 mM, the trends between monoand disaccharides are different. Both mono-and disaccharides are much more active at a concentration of 220 mM compared with 22 mM, suggesting that carbohydrate concentration influences IRI activity. The IRI activity of monosaccharides at 220 mM is approximately twice that at 22 mM. The relative potency of IRI activity for the monosaccharides is similar at 220 mM. However, the relative potencies of disaccharides are different at 220 mM. The IRI activities of disaccharides are approximately three times greater at the higher concentration than at 22 mM, but are twice as active as the monosaccharides at the same concentration (220 mM). Interestingly, the hydration index does not predict these results. If the hydration indices were to accurately predict IRI activity, D-galactose and D-melibiose would have the same IRI activity, regardless of concentration.
These observations suggest that while the hydration index is an accurate predictor of IRI activity for 22 mM solutions, the same cannot be said for higher concentrations. The hydration index of a carbohydrate is derived from isentropic partial molar compressibility values that have been reported in the literature (Hoiland and Holvik 1978; Galema and Hoiland 1991) . These values are indicative of carbohydrate hydration at infinite dilution. Failure of the hydration index to correctly predict IRI activity at 220 mM concentration may be a result of these solutions being highly concentrated and not at infinite dilution. At these high concentrations, cooperative effects from additional solute molecules may affect the hydration of the carbohydrate, thereby minimizing the effect of carbohydrate hydration and structure on IRI activity. However, it is noteworthy that the IRI activity of 220 mM solutions of mono-and disaccharides does correlate with hydration numbers reported in the literature. All hydration numbers of disaccharides are approximately equal and are twice that of monosaccharides (Tam et al. 2008) . Thus, while the hydration index fails to accurately predict the IRI activity of 220 mM disaccharide solutions, IRI activity still ultimately correlates with the degree of carbohydrate hydration.
It is worth noting that naturally occurring antifreeze glycoprotein (AFGP 8) is a very effective inhibitor of ice recrystallization and our laboratory has quantified its IRI activity at micromolar concentrations (Liu and Ben 2005; Liu et al. 2007) . By comparison, the carbohydrates are much less active. However, AFGP 8 has been shown to be a poor cryoprotectant (Mugnano et al. 1994; Wang et al. 1994 ) as these glycoproteins also exhibit dynamic ice shaping due to their ability to bind to the surface of ice (Rubinsky and DeVries 1989; Yeh and Feeney 1996; ). This ability exacerbates cellular damage during cryopreservation at temperatures outside of the thermal hysteresis gap (Rubinsky and DeVries 1989; Yeh and Feeney 1996; Liu et al. 2007 ).
IRI activity of carbohydrates with DMSO DMSO is routinely employed as a cryoprotectant for many different cell types at concentrations up to 20%. While the reported cytotoxicity of DMSO precludes its use in many instances (Davis et al. 1990; Liseth et al. 2005; Elmoazzen et al. 2007) , we have previously demonstrated that a 4% DMSO solution is an effective inhibitor of ice recrystallization (Tam et al. 2008 ). As such, we examined the effectiveness of 2.5 and 5% DMSO solutions to inhibit ice recrystallization ( Figure 2 ). From this analysis, it is apparent that both DMSO solutions (2.5 and 5.0%) exhibit IRI activity. Furthermore, the 5% DMSO solution is approximately twice as effective at inhibiting ice recrystallization as the 2.5% solution. Interestingly, the 2.5 and 5.0% DMSO solutions exhibit similar IRI activity as the 22 and 220 mM D-galactose solutions, respectively. DMSO concentrations greater than 5% are unable to be reliably assessed in the IRI assay as large portions of the ice water remained unfrozen (Tam et al. 2008) .
During cryopreservation protocols, carbohydrates are often added to DMSO solutions when preparing the cryopreservation media. For this reason, we chose to evaluate the IRI activity of a series of carbohydrates at various concentrations in combination with DMSO. One monosaccharide Fig. 1 . IRI activity of mono-and disaccharides at concentrations of 22 mM (blue bars) and 220 mM (red bars). The y-axis represents the % MGS of ice crystals relative to PBS. Blue asterisks indicate the significant difference (P < 0.05) relative to other monosaccharides at 22 mM. Red asterisks indicate the significant difference (P < 0.05) relative to other disaccharides at 220 mM.
Cryopreservation and inhibition of ice recrystallization (D-galactose) and two disaccharides (D-melibiose and D-sucrose) were arbitrarily chosen for this study. The results of this preliminary study are displayed in Figure 2 . At a 22 mM concentration, we see a large increase in IRI activity [smaller mean grain size (MGS)] for the disaccharides (D-melibiose and D-sucrose) when 2.5% DMSO is added. In contrast, the IRI activity of a 22 mM D-galactose solution remains unchanged in the presence of 2.5% DMSO. Increasing the DMSO concentration to 5% DMSO causes an additional improvement in IRI activity for all three sugars at 22 mM.
The IRI activity for the 220 mM D-galactose solution remains constant as the amount of DMSO is increased to both 2.5 and 5% solutions (Figure 2 ). Both 2.5 and 5% DMSO solutions are quite concentrated (350 and 700 mM, respectively), so it is possible that a saturation effect is occurring and this may account for the results observed here. Interestingly, the IRI activity for the 220 mM D-melibiose and D-sucrose solutions decreases upon the addition of a 2.5% DMSO solution. More surprisingly, while the IRI activity for D-melibiose remains constant as the concentration of DMSO was increased from 2.5 to 5%, we saw a further decrease in IRI activity for the 220 mM D-sucrose solution upon the same increase in DMSO concentration. From these results, it appears that the IRI activity of D-galactose at both 22 and 220 mM is not influenced by the addition of DMSO. However, DMSO appears to have a synergistic effect on IRI activity with both D-melibiose and D-sucrose at 22 mM but has an antagonistic effect with D-sucrose at a concentration of 220 mM.
Ultimately, a 220 mM D-galactose solution alone and its combination with 2.5% DMSO are as effective at inhibiting ice recrystallization as a 5% DMSO solution alone (Figure 2 ). Given the reported cytotoxicity of DMSO, lowering the DMSO concentration in combination with a carbohydrate (≤220 mM) is arguably better than using a higher concentration of DMSO. Our results suggest that the typically high concentrations of DMSO (10-15%) used in cryopreservation are not necessary to inhibit ice recrystallization. A similar result has been reported by Liseth et al. (2005) . In fact, if IRI activity is a predictor of cryopreservation ability, a 220 mM D-galactose solution should be as effective as a 5% DMSO solution and may result in less cytotoxicity and complications in patients who have undergone transplants with cells preserved using DMSO.
Assessing cytotoxicity and cryopreservation ability of monoand disaccharides While it is well documented that DMSO is cytotoxic to cells (Fahy 1986; Davis et al. 1990; Liseth et al. 2005; Yang and Sharp 2005; Elmoazzen et al. 2007 ), the cytotoxicity of carbohydrate additives has not been quantified. Consequently, we have assessed the toxicity of several mono-and disaccharides commonly utilized for cryopreservation in human embryonic liver cells (WRL-68 cells) and compared these results with 2.5 and 5% solutions of DMSO.
Given the wide range of carbohydrate concentrations employed in cryopreservation procedures (Eroglu et al. 2000; Fowler and Toner 2005; Terry et al, 2005; Hossain and Osuamkpe 2007) , the cytotoxicity of each sugar was examined at 22, 200 and 500 mM using a conventional MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay (Mosmann 1983; Liu et al. 2007 ). The results are presented in Figure 3 . It is evident from this assay that almost all carbohydrates exhibit mild cytotoxic effects to human embryonic liver cells (WRL-68). The mono-and disaccharides show similar trends at 22 and 200 mM. However, there is a significant decrease in cell viability for the disaccharides at 500 mM when compared with the other concentrations. Only a slight decrease is observed for the monosaccharides at 500 mM relative to 200 mM. Cell viability following treatment with various carbohydrates at 22 and 200 mM is approximately equal or better than viabilities with 2.5 and 5% solutions of DMSO, respectively.
Having quantified the IRI activity and cytotoxicity of simple mono-and disaccharides, these carbohydrates were assessed for their ability to preserve WRL-68 cells at subzero temperatures. Cells were cryopreserved using three different concentrations of each carbohydrate (22, 200 and 500 mM). Analysis of the cells following storage at −196°C for 7 days was performed using flow cytometry with Annexin V-PE and 7-aminoactinomycin D (7-AAD) as markers of cell viability (Figure 4) . From this data, it is apparent that all carbohydrates are poor cryoprotectants at 22 mM with total viability ranging between 30 and 45%. No significant differences between the monoand disaccharides were observed at this concentration. In general, concentrations of 200 and 500 mM are much more effective than concentrations of 22 mM, although no additional protection is conferred at 500 mM compared with 200 mM (Figure 4) . Interestingly, the same magnitude of cytotoxicity observed for the 500 mM disaccharides at 37°C (Figure 3) is not observed in the cryoassay (Figure 4) , as evidenced by the fact that cell viability post-thaw at 500 mM is comparable with that observed at 200 mM. Interestingly, several of the carbohydrates at 200 mM showed comparable viability with a 5% solution of DMSO. 
Cryopreservation and inhibition of ice recrystallization
Correlations between cytotoxicity, cryopreservation ability and IRI activity If inhibition of ice recrystallization is important for cryopreservation, then a correlation between these two properties would be expected. Consequently, we examined whether there was a correlation between IRI activity and cell viability at both physiological and subzero temperatures (Figures 5 and 6) .
The data in Figure 5 indicate that as the concentration of carbohydrate is increased, the cell viability at physiological temperatures decreases. Interestingly, 200 mM carbohydrate solutions are clustered on the bottom left corner of the graph (low viability) along with 5% DMSO, and the 22 mM solutions of carbohydrates are clustered on the top right (high viability) with 2.5% DMSO. Although the 220 mM carbohydrate solutions resulted in potent IRI activity, they also caused more cell death at physiological temperature (MTT assay, Figure 3) .
It should be noted that the disaccharides all exhibit very similar IRI activity yet have dramatically different cytotoxicity profiles, suggesting that careful choice of the carbohydrate to be used as a cryoprotectant is required. Based on these results, additional factors besides IRI activity should be taken into account when assessing cytotoxicity. Interestingly, D-lactose exhibits the best balance between effective IRI activity and cell viability at 37°C. Furthermore, 22 and 220 mM solutions of D-galactose are comparable with 2.5 and 5% solutions of DMSO in terms of both IRI activity and cytotoxicity.
Since it has been suggested that cell damage due to ice recrystallization is a major cause of cell death during freezing, we would expect there could be a correlation between IRI activity and cell viability following cryopreservation. The relationship between the IRI activity of various carbohydrates and their ability to effectively preserve WRL-68 cells post-freeze-thaw is presented in Figure 6 . Generally, higher concentrations of carbohydrates resulted in increased IRI activity and increased cell viabilities after cryopreservation. When comparing Figures 5 and 6 , the most striking difference is the change in the slope of the line of regression. This indicates that among the carbohydrates examined in this study, the most potent inhibitors of ice recrystallization are more cytotoxic at physiological temperatures, but are more effective at preserving cells at subzero temperatures.
Interestingly, the cytotoxic effects of the disaccharides at 200 mM and 37°C are negated in the cryoassay. The observed cytotoxicity of disaccharides at 37°C may be due to osmotic shock, in which a sudden change in the rate of influx or efflux of water across a cell membrane occurs as a result of the increased carbohydrate concentration (Schliess and Haussinger 2002) . Alternatively, it has been documented that glycation may occur within hours when cells are treated with carbohydrates in excess of 100 mM concentrations (Brown et al. 1992 ) and this may also account for the observed cytotoxicity (Ahmed 2005) . While additional studies are required to determine whether this is occuring, it is important to note that glycation can only occur when reducing sugars are present (Bunn and Higgins 1981) . The fact that D-sucrose and D-trehalose, which are both non-reducing disaccharides, still exhibit the same magnitude of cytotoxicity as the reducing disaccharides (D-melibiose and D-lactose) at all concentrations suggests that Schiff base formation may not be a dominant factor causing cytotoxicity.
Ideally, the best cryoprotectant would be a highly effective inhibitor of ice recrystallization and exhibit no in vitro cytotoxicity. However, in practice, better cryoprotectants are likely to exhibit a balance between cytotoxicity and cryopreservation ability. D-Galactose exhibits very little change in overall viability between physiological and subzero temperatures, suggesting that it achieves this balance. For example, 200 mM D-galactose results in 78% viability at physiological temperatures (Figure 3 ) and 75% viability post-cryopreservation (Figure 4) . In contrast, 200 mM D-glucose results in a dramatic decrease in viablity upon freezing (82% at 37°C to 50% at subzero temperatures). This balance between cytotoxicity and cryopreservation ability makes D-galactose an excellent choice for a cryoprotectant. This was an unexpected result that we deemed worthy of further investigation as it suggested that D-galactose has unrealized potential as a cryoprotectant. Fig. 5 . Percent cell viability (along with SEM) at physiological temperature (y-axis) of WRL-68 cells plotted against IRI activity (x-axis) of a series of carbohydrates at 22 mM (circles) and 220 mM (squares) and 2.5% (gray triangle) and 5% DMSO (gray diamond). Fig. 6 . Percent cell viability (along with SEM) post-freeze-thaw (y-axis) of WRL-68 cells plotted against the IRI activity (x-axis) of a series of carbohydrates at 22 mM (circles) and 220 mM (squares) and DMSO at 2.5% (gray triangle) and 5% (gray diamond) concentrations.
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There are many different hexose transporters on the surface of cells. The role of these proteins is to internalize monosaccharides such as D-glucose and D-galactose. The asialoglycoprotein receptor (ASGPr) is a hexose transporter found on the surface of liver cells (Ashwell and Morell 1974; Ashwell and Harford 1982) and its function is to internalize D-galactose and galactose-based conjugates. We hypothesized that once internalized, the ability of D-galactose to prevent intracellular ice formation and/or inhibit ice recrystallization may be mitigating cellular damage during cryopreservation resulting in increased cellular viability post-freeze-thaw. We chose to investigate this hypothesis by examining the viability of human liver HepG2 cells (human liver hepatocellular carcinoma cells) post-freeze-thaw as the ASPGr is found on the external cell membrane of these cells in large quantities and it has also been documented that binding of D-galactose to the ASPGr and subsequent internalization is inhibited using 10-20 mM solutions of ethylenediaminetetraacetic acid (EDTA) (Wall and Hubbard 1981; Kempka and Kolb-Bachofen 1985) . However, treatment of HepG2 cells with a 10 mM solution of EDTA followed by addition of either 22 or 220 mM D-galactose solutions and subsequent cryopreservation failed to decrease viability post-thaw relative to the control when binding of D-galactose to ASPGr was not inhibited (Figure 7) . Interestingly, when 1% DMSO was present with the 22 and 220 mM D-galactose solutions, cell viability post-thaw dramatically increased in comparison to that with only the sugar (Figure 7 ). However, cell viability post-thaw with a 1% DMSO and 22 mM D-galactose solution was no better than the 1% DMSO solution alone. In contrast, cell viability postthaw with a 1% DMSO and 220 mM D-galactose solution was siginificantly better than the 1% DMSO solution alone. These result suggest that internalization of D-galactose was essential to its cryoprotective ability and that the ASGPr was not responsible for this internalization. Furthermore, the cell viability post-thaw associated with a 1% DMSO and 220 mM D-galactose solution are equal to the cell viability post-thaw of a 5% DMSO solution alone.
The fact that cell viability dramatically increased when 1% DMSO was added to a 22 and 220 mM solutions of D-galactose in the HepG2 cell line during cryopreservation suggested that viability post-thaw is indeed correlated with internalization as DMSO readily permeabilizes cell membranes (Csáky and Ho 1966; Williams and Barry 2004; Notman et al. 2007 ). To further demonstrate this, a series of experiments were performed in which varying amounts of DMSO with and without 220 mM D-galactose were added to a human kidney cell line [human embryonic kidney (HEK) 293], which does not express the ASGPr on the external cell membrane. The results are presented in Figure 8 .
Note that in the absence of DMSO, cell viability is only 4% when the HEK 293 cells are cryopreserved. Even in the presence of 220 mM D-galactose, cell viability is not increased. Cell viability with increasing amounts of DMSO is constant until a 2.5% DMSO solution is added. At this concentration, or above it (5% DMSO), cell viability increases. Interestingly, when 220 mM D-galactose is added to the lower concentrations of DMSO cell viability is significantly increased in comparison to the control with only DMSO. Cell viability is maximized using a 2.5% DMSO solution in the presence of 220 mM D-galactose. A 5% DMSO solution without D-galactose results in 60% viability; however, when D-galactose is present, post-thaw viability is markedly decreased. Overall, the cryoprotective benefit of D-galactose with the HEK 293 cell line is not as evident as with the WRL-68 and HepG2 cell lines, suggesting that the benefits of D-galactose as a cryoprotectant is dependent upon the cell type. HEK 293 cells possess the GLUT1 and GLUT2 hexose transporter (Mueckler et al. 1985; Colville et al. 1993) as well as SGLT (Turk and Wright 1997; Wright et al. 2011 ) and thus Cryopreservation and inhibition of ice recrystallization will internalize D-galactose, but the fact that cell viabilities with this cell line are not as high as WRL-68 and HepG2 suggests that the HEK 293 cell line is also more suspectible to the damages associated with cryopreservation. Given the ability of DMSO to permeabilize cell membranes (Csáky and Ho 1966; Williams and Barry 2004; Notman et al. 2007) , these data support the hypothesis that increased cell viability post-thaw in the presence of D-galactose is a result of internalization. Once internalized, it may mitigate osmotic stress, prevent intracellular ice formation and/or inhibit ice recrystallization. The fact that a cryoprotective solution of 200 mM D-glucose (Figure 4) is readily transported inside the cell but is not as effective as the 200 mM D-galactose solution implies that internalization of a monosaccharide via a hexose transporter alone is not sufficient to increase cell viability.
In summary, we have examined how the IRI activity of various carbohydrates correlates with cytotoxicity and the ability of these compounds to effectively cryopreserve human embryonic liver cells. More specifically, we have demonstrated the importance of inhibiting ice recrystallization to increase cell viability post-freeze-thaw. To the best of our knowledge, this comprehensive study is the first of its kind to correlate and quantify these properties for several carbohydrates in multiple mammalian cell lines. Although 200 mM disaccharide solutions are effective cryoprotectants, a 200 mM solution of D-galactose is a very effective cryoprotectant as it is minimally cytotoxic at physiological temperature and effectively preserved cells post-freeze-thaw. In fact, it is just as effective as 5% DMSO. Our data indicates that this cryoprotective ability is likely due to internalization of D-galactose via hexose transporters where once inside the cell, it may mitigate osmotic stress, protect against intracellular ice formation and/or inhibit ice recrystallization. D-Galactose appears to be equally effective at cryopreserving two different liver cell lines, but is not as effective in a kidney cell line. While the mechanisms of cellular damage during cryopreservation are diverse and complex, the correlation between cell viability following freeze-thaw and the ability of a substance to inhibit ice recrystallization has important consequences for the design of improved cyropreservation protocols. Our results lend additional support to the hypothesis that inhibiting ice recrystallization is one of many important requirements necessary for an effective cryoprotectant (Mazur 2004; Fowler and Toner 2005) and that assessing the ability of a substance to inhibit ice recrystallization is a quick and effective manner in which to screen for novel cryoprotective agents. The predictive power of this approach on other solutes with other cell lines is currently being explored in our laboratory, and it will facilitate the development of improved cryoprotectants through rational design.
Material and methods

Carbohydrates
The mono-and disaccharides used in this study were commercially available and purchased from Sigma-Aldrich (Louisville, MI). All solutions were made up by weight, and corrections were made for the water content of the carbohydrate where necessary. (Fisher, . For HepG2 cells, 1% nonessential amino acids (Sigma-Aldrich, M7145) and sodium pyruvate (Sigma-Aldrich, P5280, final concentration of 1 mM) were added to the cell culture medium. Cells were incubated in a 37°C incubator supplied with 5% CO 2 . Passages 90-100 of WRL-68, passages 6-16 of HEK-293 and passages 5-18 of HepG2 cells were used in this study. No evidence of overgrowth or morphological changes consistent with apoptosis was observed. All cells were removed from the plates using a trypsin-EDTA solution (Sigma-Aldrich, T4174) for use in experiments.
MTT assay
The MTT assay was performed as described previously (Inada and Modak 2006) . Cells were plated in 96-well plates and treated with 40 µL of MEM supplemented with 22, 200 or 500 mM sugar (Sigma-Aldrich, D8418) and incubated at 37°C for 18 h. Cells incubated with MEM without supplement were used as a negative control, and cells supplemented with 2.5-5% DMSO in the absence of carbohydrate were used as a positive control. Following addition of 4 μL of MTT (Sigma-Aldrich, M5655) solution (5 mg/mL) in Hank's balanced salt solution (Sigma-Aldrich, H8264), plates were then incubated at 37°C with 5% CO 2 for 3 h; 100 µL of MTT solubilization solution [10% Triton X-100 (Sigma-Aldrich, X100) plus 0.1 N HCl in isopropanol] was added to each well, and each well was aspirated five times. Plates were kept covered in the dark for 18 h and the absorbance of each well was then read at a wavelength of 570 nm with a multiwell plate reader (AD 34°C Absorbance Detector, Beckman Coulter, Inc., Mississauga, ON). Viability was reported as a percentage of the control. All experiments were repeated at least two times in 16 consecutive wells for each condition.
Cryopreservation and thawing WRL-68 cells were cultured and trypsinized as described above. Cells were diluted with culture media and counted using a hemacytometer (VWR, 15170-172, Mississauga, ON). Aliquots containing 1 × 10 7 cells were added to 15 mL centrifuge tubes and cells were pelleted by centrifugation for 10 min at 580 × g. The supernatant was removed and the cells were resuspended in 1.5 mL custodial-HTK (histidine-tryptophan-ketoglutarate) solution (Methapharm, Inc., Brantford, ON) supplemented with sugar to a concentration of 22, 200 or 500 mM (Sigma-Aldrich, D8418). HTK supplemented with 2.5 or 5% DMSO served as the positive controls. Cell suspensions were transferred to 2 mL cryogenic vials (VWR, CA16001-102) and placed in a "Mr. Frosty" freezing container (Nalgene, 5100-0001; Sigma-Aldrich, C1562). The container was placed in an ultra-cold freezer (−80°C) for 24 h. According to the manufacturer, "Mr. Frosty" provides a cooling rate of 1°C/min. Samples were then stored in the vapor phase of liquid nitrogen (−196°C) for 7 days. Following storage, samples were rapidly thawed in a 37°C water bath with gentle agitation. Thawed samples were transferred to 15 mL centrifuge tubes (Diamed, STK3217P, Mississauga, ON) and slowly diluted to 3 mL by dropwise addition of Eagle's MEM (Sigma-Aldrich, M4655) cell culture medium. After 3 min, samples were further diluted to 9 mL. Cells were pelleted by centrifugation for 10 min at 580 × g. The supernatant was decanted and the pellet resuspended in 5 mL MEM. Centrifuge tubes were stored in a 37°C
water bath for 30 min during transport to the flow cytometer.
Flow cytometry
After cryopreservation and thawing (see Cryopreservation and thawing section), the cell count was determined using a hemacytometer and an aliquot containing 1 × 10 6 cells was transferred to a 15 mL centrifuge tube (Diamed, STK3217P) and diluted to 1 mL with MEM (Sigma-Aldrich, M4655) containing 10% FBS (Fisher, 361015856). Cells were pelleted by centrifugation for 10 min at 580 × g and at 4°C. The supernatant was removed and the pellet was resuspended in 1 mL Annexin-V binding buffer (BD Pharmigen, San Diego, CA, Annexin V-PE Apoptosis Detection Kit I, 559763) and 100 µL of the sample was transferred to a flow cytometry tube. Subsequently, 5 µL of 7-AAD (BD Pharmingen, Annexin V-PE Apoptosis Detection Kit I) and 4 µL of Annexin V-PE (PE) (BD Pharmingen, Annexin V-PE Apoptosis Detection Kit I) were added and samples were incubated for 20 min in the dark. Following incubation, samples were diluted to 500 µL with 1× Annexin-V binding buffer. Flow cytometry analysis on 10,000 cells was carried out on a BD LSR flow cytometer using Cell quest software (Becton Dickinson, San Diego, CA). Annexin V-PE was measured with 575 nm optical filter (FL-2), while 7-AAD was measured with 629 nm optical filter (FL-3). Complete viability was denoted as Annexin V-/7-AAD-cells. Compensation was set from single stain experiments with 7-AAD and Annexin V-PE. Aliquots from non-cryopreserved samples labeled with equivalent fluorochromes were used to set the control gate excluding 99% 7-AAD+ cells. Time between thawing and analysis by flow cytometry was 2 h. All samples were tested at least in duplicate.
IRI assay
Sample analysis for IRI activity was performed using the "splat-cooling" method (Knight et al. 1988 ) as described previously (Tam et al. 2008) . In this method, the analyte was dissolved in phosphate-buffered saline (PBS) solution and a 10 μL of this solution was dropped from a micropipette through a 2 m high-plastic tube (10 cm in diameter) onto a block of polished aluminum pre-cooled to approximately −80°C. The droplet froze instantly on the polished aluminum block and was 1 cm in diameter and 20 μm thick. This wafer was then carefully removed from the surface of the block and transferred to a cryostage held at −6.4°C for annealing. The temperature was maintained using a programmable Peltier unit (Alpha Omega Instrument 800) with a cryobath (Thermo NESLAB RTE7). After a period of 30 min, the wafer was photographed between crossed polarizing filters using a digital camera (Nikon CoolPix 5000) fitted to the microscope. For each sample, three wafers were used and a total of three images were taken from each wafer. During flash freezing, ice crystals spontaneously nucleated from the super-cooled solution. These initial crystals were relatively homogenous in size and quite small. During the annealing cycle recrystallization occurred, resulting in a dramatic increase in ice crystal size. A quantitative measure of the difference in recrystallization inhibition of two compounds X and Y is the difference in the dynamics of the ice crystal size distribution at −6.4°C. Ice recrystallization is a temperature-dependent effect and is most prevalent at temperatures slightly below 0°C. These temperatures are associated with warming or thawing of the sample after cryopreservation. While annealing temperatures closer to 0°C will accelerate the recrystallization process, resulting in larger crystals after 30 min annealing, our assay has been standardized to −6.4°C. All carbohydrate and DMSO samples were prepared and assayed as solutions in PBS. Image analysis of the ice wafers was performed using a domain recognition software program ). The MGS (or ice crystal size) was compared with the MGS of the control PBS solution for that same day of testing. The percentage of the MGS relative to the PBS control for each sample was plotted along with its standard error of the mean (SEM). Large percentages represent a large MGS, which is indicative of poor IRI activity.
Error analysis
Error bars for IRI activity were calculated by dividing the SEM for each sample by the average MGS for the PBS negative control on the day of testing. An analysis of variance (ANOVA) confirmed that the error between samples was considerably larger than the error within samples. Asterisks indicate P < 0.05 as calculated using the Student's t-test relative to the stated control in Figures 1 and 2 .
Error bars for cell viability at 37 and −196°C reflect the SEM for that sample. Again, ANOVAs confirmed that the error between samples was considerably larger than the error within samples. In all cases, the error bars reflect the measured value ± the error for that sample. Asterisks indicate P < 0.05 as calculated using the Student's t-test relative to the stated control in Figures 3, 4 , 7 and 8. 
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